After the launch of its first vaccine against Covid-19 Sputnik V, Russia is planning to register another potential vaccine candidate by 15 October, Reuters reported citing Russian news agency TASS.
Russian consumer safety watchdog Rospotrebnadzor, said that the vaccine had been developed by Siberia’s Vector Institute. The Institute has already finished early-stage human trials of the candidate last week, the report added.
Russia, earlier on 11 August, registered its first Covid-19 vaccine Sputnik V.
Sputnik V, an adenovirus vector-based vaccine, was developed by the Gamaleya Scientific Research Institute of Epidemiology and Microbiology, along with the Russian Direct Investment Fund.
Sputnik V Gam-COVID-Vac Lyo is based on the DNA of a SARS-CoV-2 type adenovirus, a common cold virus. The vaccine uses the weakened virus to deliver small parts of a pathogen and stimulate an immune response.
Disclaimer: This is a syndicated post and published without any changes except for the headlines